91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Global Beta Blockers Market Research Report 2025

Global Beta Blockers Market Research Report 2025

Publication ID: 
PB503253361
Publication Date: 
March 4, 2025
Pages: 
95
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 2,900.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Healthcare [2]
Pharma & Healthcare [3]
Description: 

The global market for Beta Blockers was valued at US$ 10940 million in the year 2024 and is projected to reach a revised size of US$ 13420 million by 2031, growing at a CAGR of 2.9% during the forecast period.
Beta blockers (also known as beta-adrenergic blocking agents) are a class of medications that are primarily used to treat heart-related conditions by blocking the effects of epinephrine (adrenaline) and norepinephrine (noradrenaline) on the beta receptors in the body. These receptors are found in various tissues, including the heart, lungs, and blood vessels.
North American market for Beta Blockers is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Beta Blockers is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Beta Blockers include AstraZeneca, Merck, Qilu Pharmaceutical, Beijing Huasu Pharmaceutical, Dainippon Sumitomo, Sumitomo Pharma, Ono Pharmaceutical, Nanjing Hicin Pharmaceutical, Gerui Pharmaceutical, Hengrui Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Beta Blockers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Beta Blockers.
The Beta Blockers market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Beta Blockers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Beta Blockers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
AstraZeneca
Merck
Qilu Pharmaceutical
Beijing Huasu Pharmaceutical
Dainippon Sumitomo
Sumitomo Pharma
Ono Pharmaceutical
Nanjing Hicin Pharmaceutical
Gerui Pharmaceutical
Hengrui Pharmaceuticals
CHIA TAI TIANQING PHARMACEUTICAL GROUP
Fosun Pharmaceutical
China National Pharmaceutical Group
Segment by Type
Nonselective Beta-Blockers
Selective Beta-Blockers
Segment by Application
Cardiovascular Disease
Other Non-Cardiovascular Diseases
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Beta Blockers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Beta Blockers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Beta Blockers Market Overview
1.1 Product Definition
1.2 Beta Blockers by Type
1.2.1 Global Beta Blockers Market Value Comparison by Type (2024 VS 2031)
1.2.2 Nonselective Beta-Blockers
1.2.3 Selective Beta-Blockers
1.3 Beta Blockers by Application
1.3.1 Global Beta Blockers Market Value by Application (2024 VS 2031)
1.3.2 Cardiovascular Disease
1.3.3 Other Non-Cardiovascular Diseases
1.4 Global Beta Blockers Market Size Estimates and Forecasts
1.4.1 Global Beta Blockers Revenue 2020-2031
1.4.2 Global Beta Blockers Sales 2020-2031
1.4.3 Global Beta Blockers Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Beta Blockers Market Competition by Manufacturers
2.1 Global Beta Blockers Sales Market Share by Manufacturers (2020-2025)
2.2 Global Beta Blockers Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Beta Blockers Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Beta Blockers, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Beta Blockers, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Beta Blockers, Product Type & Application
2.7 Global Key Manufacturers of Beta Blockers, Date of Enter into This Industry
2.8 Global Beta Blockers Market Competitive Situation and Trends
2.8.1 Global Beta Blockers Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Beta Blockers Players Market Share by Revenue
2.8.3 Global Beta Blockers Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Beta Blockers Market Scenario by Region
3.1 Global Beta Blockers Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Beta Blockers Sales by Region: 2020-2031
3.2.1 Global Beta Blockers Sales by Region: 2020-2025
3.2.2 Global Beta Blockers Sales by Region: 2026-2031
3.3 Global Beta Blockers Revenue by Region: 2020-2031
3.3.1 Global Beta Blockers Revenue by Region: 2020-2025
3.3.2 Global Beta Blockers Revenue by Region: 2026-2031
3.4 North America Beta Blockers Market Facts & Figures by Country
3.4.1 North America Beta Blockers Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Beta Blockers Sales by Country (2020-2031)
3.4.3 North America Beta Blockers Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Beta Blockers Market Facts & Figures by Country
3.5.1 Europe Beta Blockers Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Beta Blockers Sales by Country (2020-2031)
3.5.3 Europe Beta Blockers Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Beta Blockers Market Facts & Figures by Region
3.6.1 Asia Pacific Beta Blockers Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Beta Blockers Sales by Region (2020-2031)
3.6.3 Asia Pacific Beta Blockers Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Beta Blockers Market Facts & Figures by Country
3.7.1 Latin America Beta Blockers Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Beta Blockers Sales by Country (2020-2031)
3.7.3 Latin America Beta Blockers Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Beta Blockers Market Facts & Figures by Country
3.8.1 Middle East and Africa Beta Blockers Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Beta Blockers Sales by Country (2020-2031)
3.8.3 Middle East and Africa Beta Blockers Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Beta Blockers Sales by Type (2020-2031)
4.1.1 Global Beta Blockers Sales by Type (2020-2025)
4.1.2 Global Beta Blockers Sales by Type (2026-2031)
4.1.3 Global Beta Blockers Sales Market Share by Type (2020-2031)
4.2 Global Beta Blockers Revenue by Type (2020-2031)
4.2.1 Global Beta Blockers Revenue by Type (2020-2025)
4.2.2 Global Beta Blockers Revenue by Type (2026-2031)
4.2.3 Global Beta Blockers Revenue Market Share by Type (2020-2031)
4.3 Global Beta Blockers Price by Type (2020-2031)
5 Segment by Application
5.1 Global Beta Blockers Sales by Application (2020-2031)
5.1.1 Global Beta Blockers Sales by Application (2020-2025)
5.1.2 Global Beta Blockers Sales by Application (2026-2031)
5.1.3 Global Beta Blockers Sales Market Share by Application (2020-2031)
5.2 Global Beta Blockers Revenue by Application (2020-2031)
5.2.1 Global Beta Blockers Revenue by Application (2020-2025)
5.2.2 Global Beta Blockers Revenue by Application (2026-2031)
5.2.3 Global Beta Blockers Revenue Market Share by Application (2020-2031)
5.3 Global Beta Blockers Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Beta Blockers Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AstraZeneca Beta Blockers Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Beta Blockers Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Beta Blockers Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Qilu Pharmaceutical
6.3.1 Qilu Pharmaceutical Company Information
6.3.2 Qilu Pharmaceutical Description and Business Overview
6.3.3 Qilu Pharmaceutical Beta Blockers Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Qilu Pharmaceutical Beta Blockers Product Portfolio
6.3.5 Qilu Pharmaceutical Recent Developments/Updates
6.4 Beijing Huasu Pharmaceutical
6.4.1 Beijing Huasu Pharmaceutical Company Information
6.4.2 Beijing Huasu Pharmaceutical Description and Business Overview
6.4.3 Beijing Huasu Pharmaceutical Beta Blockers Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Beijing Huasu Pharmaceutical Beta Blockers Product Portfolio
6.4.5 Beijing Huasu Pharmaceutical Recent Developments/Updates
6.5 Dainippon Sumitomo
6.5.1 Dainippon Sumitomo Company Information
6.5.2 Dainippon Sumitomo Description and Business Overview
6.5.3 Dainippon Sumitomo Beta Blockers Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Dainippon Sumitomo Beta Blockers Product Portfolio
6.5.5 Dainippon Sumitomo Recent Developments/Updates
6.6 Sumitomo Pharma
6.6.1 Sumitomo Pharma Company Information
6.6.2 Sumitomo Pharma Description and Business Overview
6.6.3 Sumitomo Pharma Beta Blockers Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sumitomo Pharma Beta Blockers Product Portfolio
6.6.5 Sumitomo Pharma Recent Developments/Updates
6.7 Ono Pharmaceutical
6.7.1 Ono Pharmaceutical Company Information
6.7.2 Ono Pharmaceutical Description and Business Overview
6.7.3 Ono Pharmaceutical Beta Blockers Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ono Pharmaceutical Beta Blockers Product Portfolio
6.7.5 Ono Pharmaceutical Recent Developments/Updates
6.8 Nanjing Hicin Pharmaceutical
6.8.1 Nanjing Hicin Pharmaceutical Company Information
6.8.2 Nanjing Hicin Pharmaceutical Description and Business Overview
6.8.3 Nanjing Hicin Pharmaceutical Beta Blockers Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Nanjing Hicin Pharmaceutical Beta Blockers Product Portfolio
6.8.5 Nanjing Hicin Pharmaceutical Recent Developments/Updates
6.9 Gerui Pharmaceutical
6.9.1 Gerui Pharmaceutical Company Information
6.9.2 Gerui Pharmaceutical Description and Business Overview
6.9.3 Gerui Pharmaceutical Beta Blockers Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Gerui Pharmaceutical Beta Blockers Product Portfolio
6.9.5 Gerui Pharmaceutical Recent Developments/Updates
6.10 Hengrui Pharmaceuticals
6.10.1 Hengrui Pharmaceuticals Company Information
6.10.2 Hengrui Pharmaceuticals Description and Business Overview
6.10.3 Hengrui Pharmaceuticals Beta Blockers Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Hengrui Pharmaceuticals Beta Blockers Product Portfolio
6.10.5 Hengrui Pharmaceuticals Recent Developments/Updates
6.11 CHIA TAI TIANQING PHARMACEUTICAL GROUP
6.11.1 CHIA TAI TIANQING PHARMACEUTICAL GROUP Company Information
6.11.2 CHIA TAI TIANQING PHARMACEUTICAL GROUP Description and Business Overview
6.11.3 CHIA TAI TIANQING PHARMACEUTICAL GROUP Beta Blockers Sales, Revenue and Gross Margin (2020-2025)
6.11.4 CHIA TAI TIANQING PHARMACEUTICAL GROUP Beta Blockers Product Portfolio
6.11.5 CHIA TAI TIANQING PHARMACEUTICAL GROUP Recent Developments/Updates
6.12 Fosun Pharmaceutical
6.12.1 Fosun Pharmaceutical Company Information
6.12.2 Fosun Pharmaceutical Description and Business Overview
6.12.3 Fosun Pharmaceutical Beta Blockers Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Fosun Pharmaceutical Beta Blockers Product Portfolio
6.12.5 Fosun Pharmaceutical Recent Developments/Updates
6.13 China National Pharmaceutical Group
6.13.1 China National Pharmaceutical Group Company Information
6.13.2 China National Pharmaceutical Group Description and Business Overview
6.13.3 China National Pharmaceutical Group Beta Blockers Sales, Revenue and Gross Margin (2020-2025)
6.13.4 China National Pharmaceutical Group Beta Blockers Product Portfolio
6.13.5 China National Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Beta Blockers Industry Chain Analysis
7.2 Beta Blockers Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Beta Blockers Production Mode & Process Analysis
7.4 Beta Blockers Sales and Marketing
7.4.1 Beta Blockers Sales Channels
7.4.2 Beta Blockers Distributors
7.5 Beta Blockers Customer Analysis
8 Beta Blockers Market Dynamics
8.1 Beta Blockers Industry Trends
8.2 Beta Blockers Market Drivers
8.3 Beta Blockers Market Challenges
8.4 Beta Blockers Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned: 

AstraZeneca
Merck
Qilu Pharmaceutical
Beijing Huasu Pharmaceutical
Dainippon Sumitomo
Sumitomo Pharma
Ono Pharmaceutical
Nanjing Hicin Pharmaceutical
Gerui Pharmaceutical
Hengrui Pharmaceuticals
CHIA TAI TIANQING PHARMACEUTICAL GROUP
Fosun Pharmaceutical
China National Pharmaceutical Group

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/global-beta-blockers-market-research-report-2025

Links
[1] /countries/global[2] /healthcare[3] /pharma-healthcare